Israel Englander Ngm Biopharmaceuticals Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.17 - $1.92 $1.4 Million - $2.3 Million	-1,196,215 Reduced 94.76%	66,180 $105,000
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $688,074 - $1.5 Million	1,146,791 Added 992.0%	1,262,395 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$2.44 - $4.53 $1.34 Million - $2.48 Million	-547,362 Reduced 82.56%	115,604 $299,000
Q1 2023 May 15, 2023	BUY	$3.72 - $5.4 $761,617 - $1.11 Million	204,736 Added 44.68%	662,966 $2.71 Million
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $775,379 - $2.94 Million	227,384 Added 98.5%	458,230 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$12.59 - $17.67 $2.65 Million - $3.72 Million	-210,629 Reduced 47.71%	230,846 $3.02 Million
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $254,544 - $421,032	24,059 Added 5.76%	441,475 $5.66 Million
Q1 2022 May 16, 2022	SELL	$13.81 - $18.6 $1.61 Million - $2.17 Million	-116,933 Reduced 21.88%	417,416 $6.37 Million
Q4 2021 Feb 14, 2022	BUY	$17.26 - $22.02 $6.19 Million - $7.89 Million	358,407 Added 203.71%	534,349 $9.46 Million
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $3.11 Million - $4.04 Million	154,441 Added 718.3%	175,942 $3.7 Million
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $323,805 - $645,675	21,501 New	21,501 $424,000
Q4 2020 Feb 16, 2021	SELL	$16.21 - $31.44 $1.46 Million - $2.82 Million	-89,803 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.59 - $19.97 $1.22 Million - $1.56 Million	78,100 Added 667.35%	89,803 $1.43 Million
Q2 2020 Aug 14, 2020	SELL	$11.97 - $23.47 $998,046 - $1.96 Million	-83,379 Reduced 87.69%	11,703 $231,000
Q1 2020 May 14, 2020	BUY	$10.0 - $19.51 $266,470 - $519,882	26,647 Added 38.94%	95,082 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $539,456 - $1.1 Million	54,108 Added 377.66%	68,435 $1.27 Million
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $454,079 - $630,992	-34,689 Reduced 70.77%	14,327 $198,000
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $615,640 - $813,665	49,016 New	49,016 $718,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account